头颈部癌症患者在 COVID-19 大流行第一波期间并未经历更长的等待时间：法国专家中心的经验。
The first wave of COVID-19 did not cause longer wait times in head and neck cancer. Experience of a French expert center.
机构信息
ENT and Head and Neck Department, Huriez Hospital, Lille University, CHU Lille, rue Michel-Polonovski, 59037 Lille cedex, France.
METRICS: Evaluation des Technologies de Santé et des Pratiques Médicales - ULR 2694 - University Lille - CHU Lille, 59000 Lille, France.
出版信息
Eur Ann Otorhinolaryngol Head Neck Dis. 2022 Oct;139(5):261-267. doi: 10.1016/j.anorl.2022.03.003. Epub 2022 Apr 22.
BACKGROUND
Head and neck cancers (HNC) have poor survival prognosis, as tumors are often diagnosed at advanced stages in patients consulting late. The first lockdown linked to the 1st wave of COVID-19 (Coronavirus Disease 2019) disrupted consultation schedules in France.
OBJECTIVE
The principal aim of the present study was to analyze consultation wait time in HNC during and after lockdown, in our university expert oncology reference center, to disclose any increase in treatment wait time.
METHODS
A single-center retrospective study included patients with a first diagnosis of HNC. Three groups were distinguished: "lockdown", "post-lockdown", and a "control" group (corresponding to a reference period 1 year earlier). Intervals between first oncologic consultation and multidisciplinary tumor board (FC-MTB) and between MTB and first treatment (MTB-T) were assessed.
RESULTS
One hundred and seven patients were included in the control group, 60 in the lockdown group and 74 in the post-lockdown group. There was no increase in median FC-MTB interval (respectively 35, 29 and 28 days) between the lockdown and post-lockdown groups compared to the control group (respectively P=0.2298 and P=0.0153). Likewise, there was no increase in MTB-T interval (27, 20 and 26 days respectively) (P=0.4203).
CONCLUSION
No increase in wait times was observed during the lockdown and post-lockdown periods in our center.
背景
头颈部癌症（HNC）的预后较差，因为肿瘤通常在患者就诊较晚时被诊断为晚期。与 COVID-19（2019 年冠状病毒病）第一波相关的首次封锁打乱了法国的就诊时间表。
目的
本研究的主要目的是分析我们大学肿瘤学参考中心在封锁期间和封锁后 HNC 的就诊等待时间，以揭示治疗等待时间的任何增加。
方法
一项单中心回顾性研究纳入了首次诊断为 HNC 的患者。区分了三组：“封锁”、“封锁后”和“对照组”（对应于参考期前一年）。评估了首次肿瘤学咨询与多学科肿瘤委员会（FC-MTB）之间以及 MTB 与首次治疗之间的间隔（MTB-T）。
结果
对照组纳入 107 例患者，封锁组纳入 60 例患者，封锁后组纳入 74 例患者。与对照组相比，封锁组和封锁后组的 FC-MTB 间隔中位数（分别为 35、29 和 28 天）没有增加（分别为 P=0.2298 和 P=0.0153）。同样，MTB-T 间隔也没有增加（分别为 27、20 和 26 天）（P=0.4203）。
结论
在我们中心，封锁期间和封锁后期间没有观察到等待时间的增加。
Zotero 插件